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Abstract
To examine the role of connective tissue growth factor CCN2/CTGF (CCN2) in the maintenance of the articular cartilaginous
phenotype, we analyzed knee joints from aging transgenic mice (TG) overexpressing CCN2 driven by the Col2a1 promoter.
Knee joints from 3-, 14-, 40-, and 60-day-old and 5-, 12-, 18-, 21-, and 24-month-old littermates were analyzed. Ccn2-LacZ
transgene expression in articular cartilage was followed by X-gal staining until 5 months of age. Overexpression of CCN2
protein was confirmed through all ages in TG articular cartilage and in growth plates. Radiographic analysis of knee joints
showed a narrowing joint space and other features of osteoarthritis in 50% of WT, but not in any of the TG mice. Transgenic
articular cartilage showed enhanced toluidine blue and safranin-O staining as well as chondrocyte proliferation but reduced
staining for type X and I collagen and MMP-13 as compared with those parameters for WT cartilage. Staining for aggrecan
neoepitope, a marker of aggrecan degradation in WT articular cartilage, increased at 5 and 12 months, but disappeared at
24 months due to loss of cartilage; whereas it was reduced in TG articular cartilage after 12 months. Expression of cartilage
genes and MMPs under cyclic tension stress (CTS) was measured by using primary cultures of chondrocytes obtained from
wild-type (WT) rib cartilage and TG or WT epiphyseal cartilage. CTS applied to primary cultures of mock-transfected rib
chondrocytes from WT cartilage and WT epiphyseal cartilage induced expression of Col1a1, ColXa1, Mmp-13, and Mmp-9
mRNAs; however, their levels were not affected in CCN2-overexpressing chondrocytes and TG epiphyseal cartilage. In
conclusion, cartilage-specific overexpression of CCN2 during the developmental and growth periods reduced age-related
changes in articular cartilage. Thus CCN2 may play a role as an anti-aging factor by stabilizing articular cartilage.
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Introduction
CCN2/CTGF (CCN family member 2/connective tissue
growth factor, CCN2) is a cartilage-maintaining protein that is
dominantly expressed in cartilage; and it strongly enhances the
production of cartilaginous matrix proteins, such as type II
collagen (Col2a1) and aggrecan, as well as stimulates chondrocyte
proliferation, differentiation and maturation of growth-plate
chondrocytes under physiological conditions [1,2,3,4,5]. Although
CCN2 stimulates the proliferation and differentiation of various
types of chondrocytes, it does not stimulate hypertrophy of
articular and auricular chondrocytes [6,7]. CCN2 also enhances
the adhesion of chondrocytes to fibronectin through integrin [8]
and angiogenesis by enhancing adhesion and migration of
endothelial cells in vivo [3,9]. CCN2-deficient mice show skeletal
dysmorphism as a result of impaired chondrocyte proliferation and
extracellular matrix composition within the hypertrophic zone,
indicating that CCN2 is a crucial regulator of extracellular
cartilage matrix formation [10]. Furthermore, implantation of
CCN2-incorporated gelatin hydrogel into full-thickness defects of
rat articular cartilage accelerate cartilage repair [11].
This raises the question as to whether, and if so, to what extent
CCN2 is involved in the maintenance of the chondrocyte
phenotype and protection from degenerative changes in aging
cartilage or in osteoarthritis (OA). Multiple factors may cause OA,
the most common of all joint disorders and showing increased
incidence with age, the symptoms of which include genetic/age-
related alterations in extracellular matrix (EM) components,
biomechanical stress or an imbalance in synovial homeostasis
[12,13]. The disease is characterized by breakdown of the cartilage
matrix followed by development of surface fibrillations and
fissures, and these changes can lead ultimately to complete loss
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of articular cartilage. Another characteristic of OA is hypertrophy
and ectopic growth of bony structures in the joints. Thickening of
the subchondral bone combined with loss of articular cartilage
leads to increased stiffness and reduced shock-absorbing capacity
of the bone [14,15].
Understanding the basic mechanisms by which aging affects
joint tissues may also help to unravel new targets for treatment or
prevention of OA. Currently, there are no reliable pharmacolog-
ical agents able to prevent or even reverse degeneration of
articular cartilage occurring in OA. In animal models, osteoar-
thritis-like changes can be initiated by application of proteinases
such as matrix metalloproteinases (MMPs) and aggrecanases,
which digest type II collagen (COL2) and proteoglycan [16,17],
the principal components of the matrix of articular cartilage.
However, trials applying proteinase inhibitors for clinical use as a
disease-modifying treatment have to date been unsuccessful
because of insufficient efficacy and severely adverse side effects
[18,19], thus turning the interest of researchers to the upstream
signals of the proteinases in chondrocytes.
Joint cartilage is a permanent cartilage not destined to be
replaced by bone, unlike growth-plate cartilage, but recently
evidence is accumulating showing that in the late stages of
osteoarthritis, articular chondrocytes undergo a differentiation
process similar to that occurring during endochondral ossification
[20,21]. Several studies have shown the expression of type X
collagen (COL10) in latestage osteoarthritic cartilage [22,23]; also,
the expression of other markers of chondrocyte hypertrophy, such
as matrix metalloproteinase (MMP)-13 [24], annexin VI [25],
alkaline phosphatase [25,26], osteopontin [27], and osteocalcin
[26] are enhanced in osteoarthritic cartilage, as well as markers of
chondrocyte dedifferentiation such as type I collagen (Col1a1)
[28,29]. These findings indicate that in the case of osteoarthritis
articular chondrocytes do not maintain a stable phenotype and
lose their characteristics of permanent cartilage.
In order to elucidate the role of CCN2 during chondrogenesis,
cartilage maturation, and stabilization of the chondrocyte pheno-
type in articular cartilage, we generated mice overexpressing Ccn2
under the control of the Col2a1 promoter to clarify the role of
CCN2 in chondrogenesis and skeletogenesis, as well as in adult
cartilage. During the embryonic stage and growth period,
overexpression of CCN2 enhances chondrocyte proliferation and
the production of extracellular matrices through the induction of
IGF-I and II, resulting in enhanced endochondral bone formation
and extended bone length. Since these mice show strong
accumulation of extracellular matrix in all of their cartilages [5],
we hypothesized that overexpression of CCN2 may have an effect
on adult cartilage by conferring resistance to age-related degen-
erative changes in joints. In the present study, we analyzed knee
joints from littermates of aged CCN2 TG mice and WT controls.
Our findings indicate that cartilage-specific overexpression of
CCN2 stabilized the phenotype of articular chondrocytes in aging
mice by enhancing the synthesis of aggrecan, while suppressing
chondrocyte dedifferentiation and hypertrophy.
Materials and Methods
Animals
For overexpression of CCN2 in cartilage, HA-tagged Ccn2
cDNA and IRES-LacZ as an expression marker were cloned for
expression under the control of a 6-kb Col2a1 promoter-enhancer
(for details, please see [5]). Littermates of 3-, 14-, 40-, and 60-day-
old and 5-month-old (1 male TG and 1 male WT), 12-month-old
(2 male TG and 2 male WT), 18- 21-, and 24-month-old (2 male
TG and 1 male WT) mice were used for analysis of the knee joints.
21-month-old (5 TG, 1 male and 4 females; and 1 male WT) and
18-month-old (3 WT males and 2 WT females) mice were used to
analyze statistically the conditions of the articular cartilage of their
knee joints. Knee joints of sacrificed mice were isolated for
histology. All mice were housed in filter-top cages with paper-chip
bedding under standard pathogen-free conditions. They were fed
a standard diet with tap water provided ad libitum.
Ethics Statement
Experiments were performed according to the Animal Ethics
Committee of the Okayama University (permission #09035,
08002, 11034 for DNA recombination experiments, #OKU-
2012113 for animal experiments).
X-gal Staining
For confirmation of the expression of the transgene in articular
cartilage, LacZ activity of 14-, 40-, 60-, and 150-day-old
transgenic and wild-type mice was detected by staining with X-
gal (5-bromo-4-chloro-3-indolyl-D-galactopyranoside; Roche)
overnight following fixation in phosphate-buffered glutaraldehyde
and formaldehyde for 1 hour, as described before [8,30]. For
staining of knee joints, the skin and muscles were removed before
fixation. X-gal-stained knee joints were postfixed overnight in 4%
formaldehyde, dehydrated, and embedded in paraffin. Seven-
micrometer-thick sections were prepared by standard methods and
counterstained with eosin.
Radiographic Analysis
Degenerative changes in knee joints were analyzed by
inspecting soft-x-ray radiographs. The legs were dissected at
proximal side of the femur immediately after sacrificing the mice
to avoid external movement of the joint. Images of natural flexion
position of knee joints from the lateral side were obtained under
consistent conditions (40 kV, 5 mA for 3 sec; Fujicolor, Sofron
SRO-M50, Tokyo, Japan). Diagnostic analysis from radiographs
of knee joints was done according to previous studies on
osteoarthritic changes in STR/Ort mice [31,32,33,34].
Histology
Knee joints were dissected and fixed in 4% phosphate-buffered
formaldehyde for 24 hours. Following fixation, the samples were
defatted by passage through a series of ethanol and decalcified in
0.5 M EDTA for 3 weeks. After the tissues had been dehydrated
and embedded in paraffin, serial frontal sections of 7-mm-thickness
were cut through the knee joints. The sections were first stained
with Safranin-O-fast green [35] for detection of proteoglycans and
for measuring the thickness of the cartilage layer in the knee joints.
For toluidine blue staining, they were then deparaffinized and
rehydrated, stained with 0.1% toluidine blue for 3 minutes, and
washed in running tap water for 2 minutes. The slides were then
dehydrated and mounted with Mountquick (Daido Sangyo,
Tokyo, Japan).
Immunohistochemistry
Immunohistochemistry was done as reported previously [8].
Sections of knee joints were treated with bovine testicular
hyaluronidase (25 mg/ml) for 30 minutes at room temperature
for epitope retrieval and then immunostained with anti-CCN2
(Abcam, Cambridge, UK), anti-aggrecan neoepitope (Novus
Biologicals, Littleton, CO), anti-type I (Millipore, Billerica, MA),
type II (CII D3, [36]), and type X collagen (X53, both kindly
provided by Dr. von der Mark, University of Erlangen) and anti-
MMP13 antibodies (Millipore). Cell proliferation analysis was
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Figure 1. Overexpression of CCN2 and accumulation of type II collagen in aged articular cartilage of transgenic mice. (A–D) Frontal
sections of knee joints after X-gal staining. Specimens from 14- (A), 40- (B), 60- (C), and 150-day-old (D) TG (left) and WT (right) mice. Lower panels
show magnified regions of tibial articular cartilage as indicated by the dotted boxes in the upper panels. Expression of LacZ in the articular cartilage
was detected in the TG sections. Arrowheads indicate LacZ-positive articular chondrocytes. Bars: 200 mm. (E) Immunohistochemical staining of CCN2
in frontal sections of knee joints from 21-month-old TG and WT mice. Upper and lower panels show magnified load-bearing regions of tibial articular
cartilage (upper) and growth-plate cartilage (lower), as indicated by the dotted boxes in the middle panels. Bars: 200 mm. Deposition of CCN2 in the
upper zone of TG articular cartilage was enhanced compared with that in WT articular cartilage. (F) Immunohistochemical staining of type II collagen
in frontal sections of knee joint from 21-month-old TG and WT mice. Lower panels show magnified load-bearing regions of tibial articular cartilage, as
indicated by the dotted boxes in the upper panels. Bars: 200 mm. Accumulation of type II collagen is enhanced in TG growth-plate cartilage as
compared with WT, but in articular cartilage the difference was not significant.
doi:10.1371/journal.pone.0071156.g001
CCN2 as Anti-Aging Effect on Articular Cartilage
PLOS ONE | www.plosone.org 3 August 2013 | Volume 8 | Issue 8 | e71156
performed by using a PCNA staining kit (Invitrogen, Carlsbad,
CA) according to the manufacturer’s protocol.
Image Analysis and Statistical Analysis
The proteoglycan content and staining intensity of CCN2,
PCNA, and type I, type II and Type X collagens were assessed by
encircling the stained area; and mean of the staining intensity in
the whole area of the medial tibial cartilage was measured with a
computerized imaging system (AxioVision, ZEISS, Oberkochen,
Germany). The average intensity between the TG and WT mice
cartilage was analyzed statistically by using Student’s t-test.
For semiquantitative assessment of MMP-13 levels in the
articular cartilage, the total number of chondrocytes in equal fields
of load-bearing regions in the medial portion of the tibial cartilage
of TG and WT animals was counted, and MMP-13 levels in the
counted chondrocytes were measured densitometrically by a
computerized imaging system after staining with specific antibod-
ies. For the staining intensity of MMP-13, we measured
luminescence by using Axiovision fluorescence software, and
staining intensity was counted as dark (low) luminescence. All of
the extracted cells were pooled, and average distribution of
luminescence of TG and WT groups was compared statistically by
use of the chi (x)- square test.
Figure 2. Morphological analysis of aged knee joints from CCN2 transgenic mice. (A) X-ray photographs of knee joints from littermates of
21- (A-1) and 18-month-old (A-2) mice. 50 percent (3 out of 6) of the knee joints from WT, but none of the TG mice, developed osteoarthritis-like
phenotypes with a narrowing joint space and rough cartilage surfaces. Arrowheads indicate degenerative changes in the articular cartilage in WT
joints. (B) Safranin-O-fast green staining of frontal sections of knee joints from 21-month-old TG and WT mice. a and b: whole view of joints at low
magnification. Higher magnification of load-bearing regions of femur (a’ and b’) and tibia (a’’ and b’’), which regions are indicated by the dotted
boxes in a and b. Bars: 100 mm. More Safranin-O-positive chondrocytes remained on the surface of articular cartilage of TG mice than on that of the
WT cartilage.
doi:10.1371/journal.pone.0071156.g002
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Cyclic Tension Stress (CTS)
For transfection with the CCN2-overexpression vector, primary
cultures of growth-plate chondrocytes were prepared from the ribs
of newborn WT mice by use of collagenase treatment [8,37]. After
transfection with pEGFP/CCN2 or pEGFP DNA by electropo-
ration, the cells (16 106 cells/chamber) were plated in Flexible
chambers (STREX, Osaka, Japan) that had been pre-coated with
2 ml of 0.05 mg/ml fibronectin. For preparation of primary
cultures of articular chondrocytes from 6-day-old TG and WT
mice, the upper 2/3 part of epiphyseal cartilage (without the
growth plate) of elbow, shoulder, hip, and knee joints were taken
and treated with collagenase. The cells from TG and WT were
separately pooled and cultured in alpha-MEM (MP Biomedicals,
Solon, OH) containing 10% FCS and 50 mg/ml of ascorbic acid.
After the cells had reached confluence, the medium was changed;
and after a 24-hour incubation the chambers were moved to the
Flex cell culture system (STREX, STB-140). A cyclic tension load
of stress at 0.5 Hz, with 6% elongation was applied for 12 hours.
Then the cells were harvested for RNA preparation according to
the manufacturer’s instructions (RNeasy mini kit, QIAGEN,
Hilden, Germany). Control chambers were treated in a same way
but without CTS.
Reverse transcription was carried out by using avian myelo-
blastosis virus (AMV) reverse transcriptase with 300 ng of each
total RNA according to the manufacturer’s protocol (Takara Bio,
Ohtsu, Japan). Quantitative PCR was carried out by using the
SYBR-Green PCR assay (Toyobo, Osaka, Japan) and specific
primers, with 2 replicates. Experiments were performed with a
StepOnePlus Real-Time PCR System (Applied Biosystems, Foster
City, CA). The PCR cycling conditions were set to 10 min at 95uC
followed by 50 cycles of 30 s at 60uC, 40 s at 72uC, and 30 s at
95uC. One cDNA sample, which gave the highest copy number
for each primer set, was diluted to generating standard curves for
relative quantification of other samples. The expression level was
standardized to Gapdh. The results were evaluated statistically by
using Student’s t-test. Primers used for RT-PCR were the
following: 59-ctccacccgagttaccaatgacaa-39 and 59-ccagaaagct-
caaacttgacaggc-39 for Ccn2; 59-tggtggagcagcaagagcaa-39 and 59-
cagtggacagtagacggaggaaa-39 for Col2a1; 59-cagggttcccagtgttcagt-39
and 59-ctgctcccagtctcaactcc-39 for Aggrecan; 59-tgctgcctcaaa-
taccctttct-39 and 59-tggcgtatgggatgaagtattg-39 for ColXa1; 59-
agttggtgctaagggtgaag-39 and 59-gcaataccaggagcaccatt-39 for Co-
l1a1; 59-tcctcggagactggtaatgg-39 and 59-tgatgaaacctggacaagca-39
for Mmp-13; 59-caatccttgcaatgtggatg-39 and 59-taaggaaggggccctg-
taat-39 for Mmp-9; and 59-caatgaccccttcattgacc-39 and 59-ga-
caagcttcccgttctcag-39 for Gapdh. For overexpression of GFP-CCN2
in WT rib-cage chondrocytes, the chondrocytes were pooled from
6 to 7 embryos; and for preparation of articular chondrocytes from
TG and WT epiphyseal cartilage, the articular chondrocytes were
pooled from 2–3 WTs or TGs. Two different CTS experiments
for each cell preparation were done, and the cells were prepared 3
times and showed similar effects. The most typical results were
shown in the Figures.
Results
Overexpression of CCN2 in Articular Cartilage of
Transgenic Mice
We first examined whether and how long the expression of the
Ccn2-LacZ transgene under the control of the Col2a1 promoter
would continue to be expressed in articular cartilage of transgenic
mice after birth. X-gal-positive cells were detected in the articular
cartilage and growth plates of 14-day-old TG animals (Figure 1A).
In specimens of articular cartilage from 40-, 60- and 150-day-old
animals, X-gal-positive chondrocytes were reduced in number, but
still clearly detectable (Figure 1B, C, and D). This reduction in
transgene expression in articular cartilage with age is consistent
with the finding that adult articular chondrocytes express very low
levels of type II collagen [38].
In contrast, the immunohistochemical analysis revealed signif-
icantly enhanced accumulation of CCN2 protein in growth-plate
cartilage in the superficial and deep zones of articular cartilage of
knee joints from 21-month-old TG mice (Figure 1E, Figure S1F);
although the number of X-gal-positive cells was lower in 5-month-
old mice (Figure 1D), suggesting that overexpressed CCN2 had
stably accumulated in the extracellular matrices. To estimate the
overaccumulation of CCN2 in the TG articular cartilage during
the whole life span of the mice, we analyzed the knee joints from 3-
day-old and 5-, 12-, and 24-month-old animals (Figure S1A, B, C,
D, and E), confirming the existence of CCN2 in the TG articular
cartilage.
Since CCN2 enhances the expression of components of
extracellular matrices, there was evidence of strong accumulation
of type II collagen in the transgenic growth plate (Figure 1F).
However, in the articular cartilage, only slightly, but not
significantly enhanced accumulation of type II collagen was
observed in the deep zone of the TG articular cartilage (Figure 1F
and Figure S2A-1 and -2).
CCN2 Overexpression Prevents Degenerative Changes in
the Articular Cartilage in Aging Joints
In order to assess possible protective effects of overexpressed
CCN2 on the cartilage in aging joints, we analyzed knee joints of
all littermates from 21-month-old (1 male TG, 1 male WT, and 4
females TG) and 18-month-old WT (3 WT males and 2 WT
females) litters by X-ray analysis. In the WT knee joint, we
observed osteoarthritis-like degenerative phenotypes, as indicated
by a narrowing joint space and osteophyte-like protrusions
(marked by the arrowhead), which were not seen in the transgenic
joints. Fifty percent (3 out of 6) of the WT knee joints, but no TG
joints, developed osteoarthritis-like changes (Figure 2A-1 and -2).
CCN2 Overexpression Stabilizes Proteoglycans in
Articular Cartilage
Safranin-O staining in the superficial and middle layers of the
articular cartilage was significantly enhanced in intensity in 21-
month-old TG animals as compared with that for WT littermates
Figure 3. Enhanced proteoglycan accumulation in articular cartilage of CCN2 transgenic mice. (A) Toluidine blue (TB) staining of knee
joints from 5- (A-1), 12- (A-2), and 24-month-old (A-3) male littermates [identify animal number in each age group] (Left side: TG, right side: WT). Bars:
200 mm. left: TG and right: WT littermates. The content of TB metachromasia-positive proteoglycans decreased with aging; however, TG articular
cartilage showed a greater accumulation of proteoglycans than did the cartilage of WT littermates at all time points. (B) Histomorphometric analysis
of TB staining of knee joints from 21-month-old littermates [male (TG, #16; WT, #19), female (all TG, #14, #15, #17, #18 )], and 18-month-old
littermates [all WT (male,#1,#2,#3; female,#5,#6 )]. (B-1) Representative views of toluidine-blue stained medial tibial cartilage in the load-bearing
region (measured area outlined in green). (B-2) TB-stained knee joints. Numbers indicate individual animals. Bars: 200 mm. (B-3) Results of
densitometric analysis of specimens in B-2. Left: staining intensity from individual medial tibial cartilages. Right: mean value (Axiovision, Student’s t-
test). TG cartilage showed a significantly higher amount of proteoglycan than the WT cartilage. *: p,0.0005.
doi:10.1371/journal.pone.0071156.g003
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Figure 4. Suppression of age-related hypertrophic differentiation of deep-zone articular chondrocytes by overexpression of CCN2.
Immunohistochemical staining of type X collagen in frontal sections of knee joint. (A) Typical staining of type X collagen of the TG (left) and WT (right)
joints from 21-month-old mice. Bars: 100 mm. a and b: type X collagen staining of the medial portion of knee joint in the load-bearing region. Femora
(f) and tibia (t) are presented. a’ and b’: higher magnification of load-bearing region indicated by the dotted box in a and b, respectively. Type X
collagen-positive cells (arrowheads in b’) were observed in the deep zone of WT tibial articular cartilage, but not in those of TG cartilage. (B) Type X
collagen staining of articular cartilage (knee joints) from 21- and 18-month-old littermates. Bars: 200 mm. (C) Results of densitometric analysis of type
X collagen staining of tibial articular cartilage. Left: staining intensity of individual medial cartilage samples of tibia. Right: mean value. TG cartilage
showed a significantly lower accumulation of type X collagen compared with the WT cartilage. ***: p,0.01.
doi:10.1371/journal.pone.0071156.g004
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Figure 5. Suppression of MMP-13 expression in aging superficial and middle-zone articular chondrocytes by CCN2 overexpression.
Immunohistochemical staining of MMP-13 in frontal sections of knee joint. (A) Typical staining of MMP13 of TG (left) and WT (right) knee joints of 21-
month-old mice. Bars: 100 mm. a and b: MMP-13 staining of articular cartilage, and a’ and b’: higher magnification of medial tibial plateau in the load-
CCN2 as Anti-Aging Effect on Articular Cartilage
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(Figure 2B). Similarly, toluidine blue staining revealed a consid-
erable loss of proteoglycans in the articular cartilage of the knee
joints from 5-month- (Figure 3A-1), 12-month- (Figure 3A-2), and
24-month-old (Figure 3A-3) WT littermates compared with the
TG animals. Statistical analysis of toluidine blue staining intensity
of 21- and 18-month-old littermates showed enhanced proteogly-
can accumulation in the TG articular cartilage compared with the
accumulation in the WT animals (Figure 3B-1, -2, and -3). These
findings indicate that after overexpression of CCN2, significantly
more intact proteoglycans remained in the transgenic cartilage of
aging animals than in the WT cartilage.
CCN2 Suppresses Hypertrophic Differentiation of Deep-
zone Articular Chondrocytes
Type X collagen (COL10) is expressed to some extent in the
deep zone of normal adult human articular cartilage, but is
enhanced during osteoarthritis-like progression [22]. Furthermore,
it has been also found in the articulating surface zone of dog
cartilage after stress-induced damage to cartilage in running dogs
[39]. In 21- and 18-month-old WT mice, significant COL10
expression was detected in the deep calcified zone below the
tidemark, whereas there was much less COL10 in the deep zone of
the TG articular cartilage (Figure 4A). Statistical analysis of the
staining intensity of articular cartilage from 21- and 18-month-old
TG littermates showed significantly less staining compared with
that for the WT (Figure 4B and C), indicating that overexpression
of CCN2 may have suppressed the hypertrophic differentiation of
the articular chondrocytes. This observation is in line with our
previous report showing that CCN2 suppresses type X collagen
expression in articular chondrocytes in vitro [6].
Type I collagen was also examined, as an indicator of fibrotic
degeneration of cartilage [40,41], and was detected in the WT
articular cartilage both intracellularly and in the extracellular
cartilage matrix; whereas it was restricted to the bone and
meniscus in the TG joints (Figure S2B). These observations
indicate the beginning of chondrocyte dedifferentiation in 21- and
18-month-old WT, but not in TG, articular cartilage.
CCN2 Overexpression Suppresses Expression of MMP-13
in Superficial and Middle-zone Chondrocytes
MMP-13, a protease expressed primarily in hypertrophic
chondrocytes and involved in cartilage remodeling, was strongly
expressed in superficial- and middle-zone chondrocytes above the
tidemark in specimens from 21- and 18-month-old WT animals.
In contrast, significantly fewer MMP-13-positive chondrocytes
were seen in the TG articular cartilage (Figure 5A). Densitometric
analysis of individual cells clearly showed a reduced distribution of
the cells having high staining intensity in TG articular cartilage
(Figure 5B and C). These findings confirm that WT articular
chondrocytes underwent hypertrophic differentiation and ex-
pressed MMP-13 with aging, and indicate that CCN2 expression
suppressed this differentiation associated with MMP-13 expres-
sion.
CCN2 Overexpression Enhances Cell Proliferation in
Articular Cartilage of Aged Mice
In TG articular cartilage, a significantly larger number of
PCNA-positive chondrocytes were detected in superficial layer
compared with their number in the WT cartilage (Figure 6A).
Their location corresponded to the location of CCN2-positive
cells, indicating that CCN2 may have accelerated the proliferation
of articular chondrocytes. By contrast, much less cell proliferation
was seen in the WT articular cartilage (Figure 6B and C).
CCN2 Prevents Age-related Degeneration of
Proteoglycans in Articular Cartilage
Toluidine blue staining showed dramatically decreased proteo-
glycan accumulation in WT articular cartilage after aging, but less
changes in TG animals (Figure 7A). To estimate the degenerative
changes in WT articular cartilage, we detected the aggrecan
neoepitope. In the WT tibial articular cartilage, the level of the
aggrecan neoepitope increased dramatically in 12-month-old
mice, whereas it was reduced in the TG cartilage (Figure 7B). In
specimens obtained from 24-month-old animals, no staining was
seen in WT knee joints, due to the loss of articular cartilage;
whereas in the TG articular cartilage, aggrecan neoepitope
staining was at the level seen in the 5-month-old mice
(Figure 7B). 5-, 12-, and 24-month-old littermates (all male) were
also analyzed (Figure S3A, B, and C). WT, but not TG, mice at 12
months of age developed severe degenerative changes in their knee
joints.
WT Chondrocytes Respond to Cyclic Tension Stress (CTS)
by Enhanced Expression of Catabolic and Anabolic
Cartilage Genes, whereas CCN2-overexpressing
Chondrocytes Respond by Suppression of these Genes
There is ample evidence that mechanical stress applied to
chondrocytes activates the expression of genes involved in
chondrocyte degeneration and cartilage destruction, such as those
of MMP-13 [42] or ADAMTS-5 [43]. In order to determine
whether the CCN2 also impaired the expression of stress–induced
genes in chondrocytes, we exposed CCN2-overexpressing and
mock-transfected rib chondrocytes to CTS, and then examined
them for changes in gene expression by using real-time PCR
(Figure 8A). Overexpression of the Ccn2 in the transfected cells was
maintained during the culture period (Figure S3D, E, and F).
Application of CTS decreased the expression level of Ccn2 in Ccn2-
transfected cells; however this level was still elevated as compared
with that in the mock-transfectants (Figure 8A). Interestingly,
mock-transfected rib chondrocytes responded to cyclic stress by
enhanced expression of Col2a1, Aggrecan, Col10a1, Col1a1, and
Mmp9 mRNA; whereas CCN2-overexpressing cells responded by
undergoing slightly reduced expression of these genes, except for
Mmp13 (Figure 8A). A similar response was observed in cultures of
TG and WT epiphyseal chondrocytes (Figure 8B). Similar to the
case of CCN2-transfected rib chondrocytes, CCN2 overexpression
caused a significant increase in Col2a1 and Aggrecan expression, and
CTS caused a reduction in Col2a1 and Aggrecan expression in
bearing region indicated by the dotted box in a and b. In WT tibial articular cartilage, MMP-13-positive cells were seen in the surface zone. (B) MMP-13
staining of knee joints from 5 transgenic and 6 WT 21- and 18-month-old littermates (Left side: TG, right side: WT). Densitometric intensity of the cells
in tibial articular cartilage from each animal was measured. Bars: 50 mm. (C) Histogram of MMP13-positive cells in medial cartilage of tibia. Upper:
staining density of 5 transgenic and 6 WT samples. Lower: mean value for TG and WT. Distribution of staining intensity was analyzed by a computer
software (Axiovision, chi-square test) that originally measures ‘‘brightness’’ (the reverse of staining intensity). Most TG chondrocytes were in the peak
of low staining intensity, indicating low activity of MMP-13; whereas more WT chondrocytes were in the area of higher staining intensity, indicating
higher MMP13 accumulation.
doi:10.1371/journal.pone.0071156.g005
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Figure 6. Sustaining proliferation of articular chondrocytes in aged mice by CCN2 overexpression. (A) PCNA staining in chondrocytes of
knee joint cartilage (tibial plateau, frontal sections) of TG joints from 21-month-old mice (a) and of WT joints (b) from 18-month-old mice. a’ and b’:
higher magnification of the medial tibial plateau in the load-bearing region indicated by the dotted box in a and b. Bars: 100 mm. In TG articular
cartilage, PCNA-positive chondrocytes were observed in the surface area. Bars: 100 mm. (B) PCNA staining of knee joints from 21-month-old
littermates and 18-month-old littermates. (C) Left: Percentage of PCNA-positive cells per total cells in TG or WT tibia medial cartilage of individual
mice. Right: mean value for TG and WT. TG cartilage showed a significantly higher ratio of PCNA-positive chondrocytes than WT cartilage. *: p,0.001.
doi:10.1371/journal.pone.0071156.g006
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CCN2 transgenic epiphyseal chondrocytes. WT epiphyseal
chondrocytes, however, did not respond to CTS by enhancing
their expression of Col2a1 and Aggrecan. Similar to that in rib
chondrocytes, Col10a1 expression was only stimulated by CTS in
WT epiphyseal chondrocytes cells, but was not affected in CCN2-
overexpressing cells.
Also with respect to expression of Mmps, rib and epiphyseal
chondrocytes responded to CTS in a similar manner: Expression
of Mmp13 was stimulated by CTS in mock-transfected and WT
chondrocytes, but impaired in CCN2-overexpressing rib and
epiphyseal chondrocytes. Expression of Mmp9 was also stimulated
in mock-transfected and WT cells, but not altered in CCN2-
overexpressing cells (Figure 8A, B, and Supporting Information
S1).
These results indicate that overexpression of Ccn2 stimulated the
expression of cartilage matrix genes in hyaline chondrocytes, but
conferred resistance to degenerative changes generated by
mechanical stress.
Figure 7. Preventing age-related degeneration of proteoglycans in articular cartilage by CCN2 overexpression. (A) Toluidine blue
staining of frontal sections of medial portion of TG (a, c, e) and WT (b, d, f) littermate knee joints from 5- (a and b), 12- (c and d), and 24- (e and f)
month-old male mice. TB staining indicated that WT articular cartilage was degraded with age, and finally the whole layer was lost after 24 months.
(B) Immunohistochemical staining of aggrecan neoepitope in frontal sections of the medial portion of TG (a, c, e) and WT (b, d, f) littermate knee
joints from 5- (a and b), 12- (c and d), and 24-month-old (e and f) mice. a’, b’, c’, d’, e’, and f’: higher magnification of the medial tibial plateau in the
load-bearing region, indicated by the dotted box in a, b, c, d, e, and f, respectively. Bars: 200 mm. In the WT tibia (d and d’) even the remaining
matrices were slightly degraded, as shown by the aggrecan neoepitope staining. TG cartilage showed a minor decrease in staining for the aggrecan
neoepitope (a’, c’, and e’), but not severe as in the WT cartilage (b’, d’, and f’).
doi:10.1371/journal.pone.0071156.g007
Figure 8. CCN2 overexpression reduces cyclic tension stress (CTS)-induced gene expression changes in cultured chondrocytes. (A)
Gene expression analysis of cartilage matrix constituents and proteases of GFP-CCN2 overexpressing rib chondrocytes or mock transfectants after
application of cyclic tension stress (CTS) (+). Control cells without CTS (2). Primary cultures of mouse rib chondrocytes overexpressing GFP-CCN2 or
GFP as a control were subjected to CTS at 0.5 Hz, with 6% elongation, for 12 hours; and gene expression was then measured by RT-PCR. The
expression of transfected Ccn2 was decreased after CTS. The expression of Col2a1, Aggrecan, ColXa1, Col1a1, Mmp13, andMmp9 genes was stimulated
after CTS application to mock cells, but was slightly reduced or remained equal when CTS was applied to CCN2-overexpressing rib chondrocytes after
CTS. *: p,0.05 **: p,0.01 ***: p,0.005 (B) Gene expression analysis of cartilage matrix constituents and proteases in cultures of epiphyseal
chondrocytes from 6-day-old TG and WT mice, subjected to after CTS as in (A). Contrary to that in rib chondrocytes, the expression of Col2a1 and
Aggrecan was decreased when CTS was applied to WT cells. The expression of Col1a1, ColXa1, and Mmp9 genes was stimulated by CTS in WT cells,
but down-regulated in the TG chondrocytes. Mmp13 gene was also reduced in the TG chondrocytes by CTS. *: p,0.05 **: p,0.01 ***: p,0.005 (C)
Cartilage-specific overexpression of CCN2 under the control of type II collagen promoter alleviated the development of degenerative changes in
aging articular cartilage such as decreases in proteoglycan and type II collagen and enhanced expression of type X and I collagens and MMP-13.
doi:10.1371/journal.pone.0071156.g008
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Discussion
In this study, we evaluated the in vivo effect of cartilage-specific
overexpression of CCN2 on the maintenance of knee joint
cartilage in aging CCN2-transgenic mice. In the knee joints of
12-, 18-, 21-, and 24-month-old WT mice, articular cartilage
showed degenerative changes such as proteoglycan loss, surface
erosion, enhanced chondrocyte hypertrophy, and enhanced type I
collagen expression, all of which are characteristic changes in
aging mice [44,45] and similar to the age-related changes seen in
STR/Ort mice [31]. CCN2 overexpression in the articular
cartilage under the control of the Col2a1 promoter alleviated
these degenerative changes and signs of chondrocyte degeneration
1) by promoting Aggrecan and Col2a1 synthesis, 2) by suppressing
synthesis and deposition of markers of chondrocyte hypertrophy
(Col10a1), chondrocyte dedifferentiation (Col1a1), and cartilage
degradation (Mmp9 and Mmp13), and 3) by promoting chondro-
cyte proliferation. These results indicate that the overexpression of
CCN2 conferred a protective effect on articular cartilage against
degenerative changes with aging by promoting chondrocyte
proliferation and proteoglycan synthesis.
In TG mice, overexpressed CCN2 protein accumulated in the
superficial and middle zones of the articular cartilage, and the
chondrocytes remained proliferative in these layers. Safranin-O
and toluidine blue staining indicated significantly more intact
proteoglycans remaining in 5-, 12-, 21-, and 24-month-old TG
articular cartilage than in WT cartilage. Similar, slightly enhanced
deposition of type II collagen was found in CCN2 TG articular
cartilage as compared with that in WT littermates. These findings
are consistent with several reports showing stimulation of Col2a1
and Aggrecan expression in cartilage by CCN2 [3,5].
Under physiological conditions, only chondrocytes of the deep
zone below the tidemark, but not those of the superficial and
middle zone of young articular cartilage undergo hypertrophic
differentiation; whereas those in the superficial and middle zone
maintain a stable phenotype as a permanent cartilage [22,23].
With aging or after exposure to an excessive mechanical load,
however, partial hypertrophy of chondrocytes in the superficial
and middle zones associated with enhanced type X collagen
expression has been reported to occur in mouse and canine
articular cartilage [46,47,48]. In OA, pathologic expression of type
X collagen and that of other markers of hypertrophy such as
annexin VI, alkaline phosphatase, osteopontin, and osteocalcin
have been observed in deep, superficial and middle zones of
articular cartilage [22,47,49].
Type X collagen deposition in aging articular cartilage was
suppressed by CCN2 overexpression. The real-time PCR analysis
of CCN2-overexpressing rib and epiphyseal chondrocytes after the
addition of CTS did not indicate suppression of Col10a1
expression at the mRNA level; however, since CTS stimulated
the expression of Col10a1 and Col1a1 in both mock-transfected rib
chondrocytes and WT epiphyseal chondrocytes. The reduced type
X and type I collagen deposition in CCN2 transgenic cartilage is
consistent with the Col2a1- and Aggrecan-stimulating effect of
CCN2, which stabilizes the hyaline phenotype of chondrocytes.
The stimulation of chondrocyte proliferation by CCN2 might have
additionally contributed to stabilization of the cartilage phenotype
in CCN2 transgenic mice.
Numerous studies have shown that moderate mechanical stress
stimulates matrix synthesis of articular cartilage, whereas excess
mechanical stress is a major cause of secondary osteoarthritis [20].
Adaptation of articular cartilage to mechanical stimulation is
related to the interaction between the chondrocytes and the matrix
[50,51]. Accumulated extracellular matrices may act as a shock
absorber to the mechanical load in the joints. On the other hand, a
recent report showed that the postnatal ablation of Sox9
dramatically decreases type II collagen mRNA and aggrecan
contents; however, no histopathological signs of osteoarthritis were
observed [52], indicating that the amount of extracellular matrix
in articular cartilage is important but may not be necessary for the
development of degradative changes in articular cartilage.
MMP-13, a protease produced by late hypertrophic chondro-
cytes [18] and which potently degrades cartilage matrix with a
preference for type II collagen, is known to be induced in OA
articular cartilage and to be functionally involved in OA
pathogenesis [53]. This proteinase has been suggested to be
induced in response to proinflammatory cytokines such as tumor
necrosis factor a (TNFa), interleukin-1 (IL-1), and IL-6 in articular
cartilage under pathologic conditions, such as found in OA and
rheumatoid arthritis (RA) [54]. However, it is questionable
whether these cytokines play significant roles in the development
of OA.
Col2a1 and Aggrecan expression was stimulated in mock rib
chondrocytes by CTS, but slightly inhibited or not affected in WT
epiphyseal chondrocytes (Figure 6B and C). These results may
relate to the difference in the source of chondrocytes and their
differential response to CTS [55,56,57].
Recent reports claimed that applying excessive load to a joint
induces neovascularization at the region of the articular cartilage
from synovium or tendon; subsequently, endochondral ossification
can be initiated and osteophytes are formed [21]. Although CCN2
also promotes angiogenesis [3,9] the CCN2-overexpressing area in
the articular cartilage was spatially separated from the peripheral
surface region. In addition, cartilage contains many anti-angio-
genic factors such as chondromodulin-1 [58] and TIMP-2 [59].
Altogether, the protective effects of CCN2 in articular cartilage
against aging and degeneration such as by stimulating chondrocyte
proliferation and proteoglycan synthesis, as well as by suppressing
protease expression seem to outweigh any potential angiogenic
effects of CCN2 in cartilage. This is in line with our previous
reports showing that CCN2 stimulates the proliferation and
differentiation, but not hypertrophy, of articular chondrocytes [6].
In conclusion, we have demonstrated that overexpression and
accumulation of CCN2 in the extracellular matrices protects
articular cartilage from age-related degenerative changes. Adult
transgenic articular cartilage showed higher levels of proteoglycans
as compared with those of littermates. Ccn2 transgene expression
levels were also enhanced in transgenic cartilage, as expected;
although their expression levels were lower than those of growing
and younger ages. In a recent study we showed that Ccn2
transgenic mice have a strongly enhanced accumulation of
extracellular matrix, accelerated endochondral ossification, and
extended bone growth [5]. The protective effects of CCN2 against
degenerative changes in CCN2-overexpressing TG chondrocytes
may have also been due to the enhanced accumulation of
cartilaginous extracellular matrices at younger ages. Enhanced
matrix accumulation may also explain the lower responsiveness of
CCN2 transgenic chondrocytes to excess mechanical stress-
induced changes (Figure 8C). The cellular mechanism of the
cartilage-protective effects of CCN2 still needs to be elucidated.
Supporting Information
Figure S1 Accumulation of CCN2 in transgenic articular
cartilage at different age and comparison of CCN2
accumulation in transgenic littermates. (A–E) Immunohis-
tochemical staining of CCN2. Knee joints from 3-day (A), 60-day
(B), 5-month (C), 12- (D), and 24-month-old (E) littermates. (F-1)
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Comparison and densitometric analysis of medial knee joints from
21- and 18-month-old littermates [identify animal number in each
age group] (Left side: TG, right side: WT). Staining area was
circled, and the staining intensity was measured. Bars: 200 mm. (F-
2) Left: staining intensity of individual medial tibial cartilages.
Right: mean value. TG cartilage showed a significantly higher
amount of accumulated CCN2 compared with the WT cartilage.
*: p,0.005.
(TIF)
Figure S2 Comparison of type II and I collagen
accumulation in articular cartilage between CCN2
transgenic littermates. (A) Immunohistochemical staining of
type II collagen. (A-1) Comparison and densitometric analysis of
medial knee joints from 21- and 18-month-old littermates [identify
animal number in each age group] (Left side: TG, right side: WT).
Bars: 200 mm. (A-2) The staining area of each specimen was
circled; and the staining intensity of it was measured. Left: staining
intensity from individual medial tibial cartilages. Right: mean
value. Accumulation of type II collagen in the medial tibial
cartilage was not significantly different between TG and WT.
p=0.496 (B) Immunohistochemical staining of type I collagen in
frontal sections of knee joints. (B-1) Typical staining of type I
collagen of TG (left) and WT (right) joints from 21-month-old
mice. Bars: 100 mm. Upper photos: type I collagen staining of the
medial side of knee joints in the load-bearing region. Lower
photos: higher magnification of load-bearing region indicated by
the dotted box in the upper photos. In WT tibial articular
cartilage, type I collagen-positive cells are marked by arrowheads.
(B-2) Type I collagen staining of knee joints from 21- and 18-
month-old littermates [identify animal number in each age group]
(Left side: TG, right side: WT). (B-3) The staining area was circled;
and the staining intensity of it was measured. Left: staining
intensity of individual medial cartilage of tibia. Right: mean value.
TG cartilage showed a significantly lower amount of type I
collagen deposition than WT cartilage. ***: p,0.01.
(TIF)
Figure S3 Detection of aggrecan neoepitope in articular
cartilage from transgenic littermates at different age
and expression analysis of pEGFP/ccn2 vector in
chondrocytes. (A–C) Immunohistochemical staining of aggre-
can neoepitope of medial knee joints from 5- (A), 12- (B), and 24-
month-old (C) whole littermates [identify animal number in each
age group]. Lower panels show magnified load-bearing regions of
tibial articular cartilage indicated by the dotted boxes in the upper
panels. In WT articular cartilage from 12-month-old mice,
aggrecan neoepitope-positive extracellular matrices were observed
in the surface area; and in other WT littermates at 12 months of
age (B, lower panel) and at 24 months of age (C, lower panel),
almost no staining occurred, due to the loss of articular cartilage.
In contrast, TG articular cartilage, which was quite intact, showed
no change in staining intensity (A, B, and C, upper panel). Bars:
200 mm. (D–F) Expression analysis of GFP-CCN2 in primary rib
chondrocytes that had been transfected with GFP-CCN2
expression vector or empty vector (mock). (D) Immunoblot
analysis of overexpressed GFP-CCN2 in chondrocytes, as
performed with anti-GFP antibody. Primary rib chondrocytes
were isolated and transfected with the GFP-CCN2 or mock
expression vector. The cells were cultured in ex chambers as in the
case of CTS-loaded cells. The cells were lysed by lysis buffer
(10 mM Na-phosphate buffer at pH7.2, 150 mM NaCl, 1%
Triton X-100, 0.1% SDS, 1 mM DTT, 0.1 mM PMSF), and the
same amount of proteins was loaded into 12% SDS-PAGE gels.
(E) Gene expression analysis of overexpressed Ccn2 by real-time
PCR. The cells, which were prepared by the same methods as
indicated in (D) were used for preparation of total RNA. For real-
time PCR analysis, primer sets were designed for the outside of the
CCN2-coding region, and standardization was done with Gapdh.
(F) Fluorescent images of GFP-CCN2-overexpressing cells. Before
the cells had reached confluence, they fixed and stained with
DAPI. a: GFP, b: DAPI, and c: merge.
(TIF)
Supporting Information S1 Gene expression analysis of
cartilage matrix constituents and proteases of epiphy-
seal chondrocytes from 6-day-old TG and WT mice after
CTS. The experiment was done several times, and the most
typical results were shown in Figure 8.
(TIF)
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